Metabolic acidosis-induced insulin resistance and cardiovascular risk

Metabolic Syndrome and Related Disorders

Volumn 9, Issue 4, 2011, Pages 247-253

  Souto, Gema ^a   Donapetry, Cristóbal ^b   Calviño, Jesús ^b   Adeva, María M ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b Hospital General Juan Cardona   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

AGING; ATHEROMATOSIS; BODY WEIGHT; CARDIOVASCULAR RISK; CHRONIC KIDNEY FAILURE; DEVELOPED COUNTRY; DIET; DIETARY INTAKE; DISEASE ASSOCIATION; FRUIT; GENETIC ASSOCIATION; HUMAN; HYPERTENSION; INSULIN RESISTANCE; METABOLIC ACIDOSIS; METABOLIC REGULATION; METABOLIC SYNDROME X; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; REVIEW; SEDENTARY LIFESTYLE; VEGETABLE;

ACIDOSIS; ALBUMINURIA; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; DIET; HUMANS; INSULIN RESISTANCE; KIDNEY FAILURE, CHRONIC; MODELS, BIOLOGICAL; RISK FACTORS;

EID: 79960789693     PISSN: 15404196     EISSN: 15578518     Source Type: Journal    
DOI: 10.1089/met.2010.0108     Document Type: Review

References (74)

1. Bianchi S, Bigazzi R, Valtriani C, Chiapponi I, Sgherri G, Baldari G, Natali A, Ferrannini E, Campese VM. Elevated serum insulin levels in patients with essential hypertension and microalbuminuria. Hypertension 1994;23(6 Pt 1):681-687. (Pubitemid 24180796)
2. Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Arch Intern Med 1997;157:1413-1418. (Pubitemid 27300386)
3. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984;310:356-360. (Pubitemid 14179541)
4. Jarrett RJ, Viberti GC, Argyropoulos A, Hill RD, Mahmud U, Murrells TJ. Microalbuminuria predicts mortality in non-insulin- dependent diabetics. Diabet Med 1984;1:17-19. (Pubitemid 14004823)
5. Borch-Johnsen K, Kreiner S. Proteinuria: Value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. Br Med J 1987;27:1651-1654. (Pubitemid 17088017)
6. Jensen T, Borch-Johnsen K, Kofoed-Enevoldsen A, Deckert T. Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: Incidence and risk factors. Diabetologia 1987;30:144-148. (Pubitemid 17056998)
7. Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey. Lancet 1988;3:530-530.
8. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, Halle JP, Young, J, Rashkow A, Joyce C, Nawaz S, Yusuf S for the HOPE Study Investigators. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001;286:421-426. (Pubitemid 32681484)
9. Wachtell K, Ibsen H, Olsen MH, Borch-Johnsen K, Lindholm LH, Mogensen CE. Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Ann Intern Med 2003;139:901-906.
10. Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, Jensen G, Clausen P, Scharling H. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 2004;6:32-35. (Pubitemid 38880131)
11. Chronic Kidney Disease Prognosis Consortium. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010;375:2073-2081.
12. Watts GF, Naumova R, Slavin BM, Morris RW, Houlston R, Kubal C, Shaw KM. Serum lipids and lipoproteins in insulindependent diabetic patients with persistent microalbuminuria. Diabet Med 1989;6:25-30. (Pubitemid 19020760)
13. Jones SL, Close CF, Mattock MB, Jarrett RJ, Keen H, Viberti GC. Plasma lipid and coagulation factor concentrations in insulin dependent diabetics with microalbuminuria. BMJ 1989;298:487-490. (Pubitemid 19072075)
14. Niskanen L, Uusitupa M, Sarlund H, Siitonen O, Voutilainen E, Penttilä I. Microalbuminuria predicts the development of serum lipoprotein abnormalities favouring atherogenesis in newly diagnosed type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1990;33:237-243. (Pubitemid 20136241)
15. Haffner SM, Stern MP, Gruber MK, Hazuda HP, Mitchell BD, Patterson JK. Microalbuminuria. Potential marker for increased cardiovascular risk factors in nondiabetic subjects? Arteriosclerosis 1990;10:727-731. (Pubitemid 20273345)
16. Yip J, Mattock MB, Morocutti A, Sethi M, Trevisan R, Viberti G. Insulin resistance in insulin-dependent diabetic patients with microalbuminuria. Lancet 1993;342:883-887. (Pubitemid 23291590)
17. Nosadini R, Solini A, Velussi M, Muollo B, Frigato F, Sambataro M. Impaired insulin-induced glucose uptake by extrahepatic tissue is hallmark of NIDDM patients who have or will develop hypertension and microalbuminuria. Diabetes 1994;43:491-499. (Pubitemid 24064259)
18. Parvanova AI, Trevisan R, Iliev IP, Dimitrov BD, Vedovato M, Tiengo A, Remuzzi G, Ruggenenti P. Insulin resistance and microalbuminuria: A cross-sectional, case-control study of 158 patients with type 2 diabetes and different degrees of urinary albumin excretion. Diabetes 2006;55:1456-1462. (Pubitemid 44195387)
19. Mykkänen L, Zaccaro DJ, Wagenknecht LE, Robbins DC, Gabriel M, Haffner SM. Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study. Diabetes 1998;47:793-800. (Pubitemid 28201810)
20. Rademacher ER, Sinaiko AR. Albuminuria in children. Curr Opin Nephrol Hypertens 2009;18:246-251.
21. Ekstrand AV, Groop PH, Grönhagen-Riska C. Insulin resistance precedes microalbuminuria in patients with insulindependent diabetes mellitus. Nephrol Dial Transplant 1998;13:3079-3083. (Pubitemid 28534711)
22. Niskanen L, Laakso M. Insulin resistance is related to albuminuria in patients with type II (non-insulin-dependent) diabetes mellitus. Metabolism 1993;42:1541-1545. (Pubitemid 24001169)
23. Klausen KP, Parving HH, Scharling H, Jensen JS. The association between metabolic syndrome, microalbuminuria and impaired renal function in the general population: impact on cardiovascular disease and mortality. J Intern Med 2007; 262:470-478. (Pubitemid 47404367)
24. de Boer IH, Sibley SD, Kestenbaum B, Sampson JN, Young B, Cleary PA. Diabetes Control and Complications Trial/ Epidemiology of Diabetes Interventions and Complications Study Research Group. Central obesity, incident microalbuminuria, and change in creatinine clearance in the epidemiology of diabetes interventions and complications study. J Am Soc Nephrol 2007;18:235-243. (Pubitemid 46053436)
25. Bonnet F, Marre M, Halimi JM, Stengel B, Lange C, Laville M. DESIR Study Group. Waist circumference and the metabolic syndrome predict the development of elevated albuminuria in non-diabetic subjects: The DESIR Study. J Hypertens 2006;24:1157-1163. (Pubitemid 43772324)
26. Saraheimo M, Forsblom C, Fagerudd J, Teppo AM, Pettersson-Fernholm K, Frystyk J. FinnDiane study group. Serum adiponectin is increased in type 1 diabetic patients with nephropathy. Diabetes Care 2005;28:1410-1414. (Pubitemid 40756705)
27. DeFronzo RA, Beckles AD. Glucose intolerance following chronic metabolic acidosis in man. Am J Physiol 1979;236: E328-E334. (Pubitemid 9174543)
28. Lovejoy J, Newby FD, Gebhart SS, DiGirolamo M. Insulin resistance in obesity is associated with elevated basal lactate levels and diminished lactate appearance following intravenous glucose and insulin. Metabolism 1992;41:22-27.
29. Walker BG, Phear DN, Martin FIR, Baird CW. Inhibition of insulin by acidosis. Lancet 1963;9:964-965.
30. Ginsberg HN. Investigation of insulin sensitivity in treated subjects with ketosis-prone diabetes mellitus. Diabetes 1977;26:278-283. (Pubitemid 8086527)
31. DeFronzo RA, Andres R, Edgar P, Walker WG. Carbohydrate metabolism in uremia: A review. Medicine 1973;52:469-481.
32. Farwell WR, Taylor EN. Serum bicarbonate, anion gap and insulin resistance in the National Health and Nutrition Examination Survey. Diabet Med 2008;25:798-804.
33. Cupisti A, Meola M, D'Alessandro C, Bernabini G, Pasquali E, Carpi A, Barsotti G. Insulin resistance and low urinary citrate excretion in calcium stone formers. Biomed Pharmacother 2007;61:86-90. (Pubitemid 46185875)
34. Abate N, Chandalia M, Cabo-Chan AV Jr., Moe OW, Sakhaee K. The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int 2004;65:386-392. (Pubitemid 38130632)
35. Takahashi S, Inokuchi T, Kobayashi T, Ka T, Tsutsumi Z, Moriwaki Y. Relationship between insulin resistance and low urinary pH in patients with gout, and effects of PPARalpha agonists on urine pH. Horm Metab Res 2007;39:511-514. (Pubitemid 47204195)
36. Maalouf NM, Cameron MA, Moe OW, Adams-Huet B, Sakhaee K. Low urine pH: A novel feature of the metabolic syndrome. Clin J Am Soc Nephrol 2007;2:883-888
37. Sakhaee K, Adams-Huet B, Moe OW, Pak CY. Pathophysiologic basis for normouricosuric uric acid nephrolithiasis. Kidney Int 2002;62:971-979. (Pubitemid 35316727)
38. Taylor EN, Forman JP, Farwell WR. Serum anion gap and blood pressure in the national health and nutrition examination survey. Hypertension 2007;50:320-324. (Pubitemid 47205780)
39. Forman JP, Rifas-Shiman SL, Taylor EN, Lane K, Gillman MW. Association between the serum anion gap and blood pressure among patients at Harvard Vanguard Medical Associates. J Hum Hypertens 2008;22:122-125.
40. Taylor EN, Mount DB, Forman JP, Curhan GC. Association of prevalent hypertension with 24-hour urinary excretion of calcium, citrate, and other factors. Am J Kidney Dis 2006;47:780-789.
41. Murakami K, Sasaki S, Takahashi Y, Uenishi K. Japan Dietetic Students Study for Nutrition and Biomarkers Group. Association between dietary acid-base load and cardiometabolic risk factors in young Japanese women. Br J Nutr 2008;100:642-651.
42. Bresslau NA, Brinkley L, Hill KD, Pak CY. Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism. J Clin Endocrinol Metab 1988;66:140-146. (Pubitemid 18027743)
43. Demigne C, Sabboh H, Remesy C, Meneton P. Protective effects of high dietary potassium: nutritional and metabolic aspects. J Nutr 2004;134:2903-2906. (Pubitemid 39470059)
44. Frassetto LA, Morris RC Jr, Sebastian A. Effect of age on blood acid-base composition in adult humans: Role of agerelated renal functional decline. Am J Physiol 1996;271:F1114-F1122.
45. Buchanan TA, Xiang AH, Peters RK, Kjos SL, Marroquin A, Goico J. Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. Diabetes 2002;51:2796-2803. (Pubitemid 34970933)
46. Valachovicová M, Krajcovicová-Kudlacková M, Blazicek P, Babinská K. No evidence of insulin resistance in normal weight vegetarians. A case control study. Eur J Nutr 2006;45:52-54. (Pubitemid 43221284)
47. Barnard ND, Scialli AR, Turner-McGrievy G, Lanou AJ, Glass J. The effects of a low-fat, plant-based dietary intervention on body weight, metabolism, and insulin sensitivity. Am J Med 2005;188:991-997. (Pubitemid 41297763)
48. Colditz GA, Manson JE, Stampler MJ, Rosner B, Willet WC, Spelzer FE. Diet and risk of clinical diabetes in women. Am J Clin Nutr 1992;55:1018-1023.
49. Humphries S, Kushner H, Falkner B. Low dietary magnesium is associated with insulin resistance in a sample of young, nondiabetic Black Americans. Am J Hypertens 1999;12:747-756. (Pubitemid 29416789)
50. Huerta MG, Roemmich JN, Kington ML, Bovbjerg VE, Weltman AL, Holmes VF. Magnesium deficiency is associated with insulin resistance in obese children. Diabetes Care 2005;28:1175-1181. (Pubitemid 40616631)
51. Kao WH, Folsom AR, Nieto FJ, Mo JP, Watson RL, Brancati FL. Serum and dietary magnesium and the risk for type 2 diabetes mellitus: The Atherosclerosis Risk in Communities Study. Arch Intern Med 1999;159:2151-2159. (Pubitemid 29483154)
52. Fung TT, Chiuve SE, McCullough ML, Rexrode KM, Logroscino G, Hu FB. Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women. Arch Intern Med 2008;168:713-720. (Pubitemid 351563954)
53. Avogaro A, Crepaldi C, Miola M, Maran A, Pengo V, Tiengo A, Del Prato S. High blood ketone body concentration in type 2 non-insulin dependent diabetic patients. J Endocrinol Invest 1996;19:99-105. (Pubitemid 26107179)
54. Hood VL, Keller U, Haymond MW, Küry D. Systemic pH modifies ketone body production rates and lipolysis in humans. Am J Physiol 1990;259:E327-E334. (Pubitemid 20320754)
55. Sartorius OW, Roemmelt JC, Pitts RF, Calhoon D, Miner P. The renal regulation of acid-base balance in man. The nature of the renal compensations in ammonium chloride acidosis. J Clin Invest 1949;28:423-439
56. Sulyok E, Guignard JP. Effect of ammonium-chloride-induced metabolic acidosis on renal electrolyte handling in human neonates. Pediatr Nephrol 1990;4:415-420. (Pubitemid 20252804)
57. Györke ZS, Sulyok E, Guignard JP. Ammonium chloride metabolic acidosis and the activity of renin-angiotensin-aldosterone system in children. Eur J Pediatr 1991;150:547-549.
58. Garibotto G, Verzola D, Sofia A, Saffioti S, Menesi F, Vigo E. Mechanisms of renal ammonia production and protein turnover. Metab Brain Dis 2009;24:159-167.
59. Bosch JP, Saccaggi A, Lauer A, Ronco C, Belledonne M, Glabman S. Renal functional reserve in humans. Effect of protein intake on glomerular filtration rate. Am J Med 1983;75:943-950. (Pubitemid 14204584)
60. Kontessis P, Jones S, Dodds R, Trevisan R, Nosadini R, Fioretto P. Renal, metabolic and hormonal responses to ingestion of animal and vegetable proteins. Kidney Int 1990;38:136-144. (Pubitemid 20209443)
61. de Santo NG, Capasso G, Malnic G, Anastasio P, Spitali L, D'Angelo A. Effect of an acute oral protein load on renal acidification in healthy humans and in patients with chronic renal failure. J Am Soc Nephrol 1997;8:784-792. (Pubitemid 27493592)
62. Barnard ND, Cohen J, Jenkins DJA, Turner-McGrievy G, Gloede L, Jaster B, Seidl K, Green AA, Talpers S. A low-fat vegan diet improves glycemic control and cardiovascular risk factors in a randomized clinical trial in individuals with type 2 diabetes. Diabetes Care 2006;29:1777-1783. (Pubitemid 44156629)
63. Azadbakht L, Atabak S, Esmaillzadeh A. Soy protein intake, cardiorenal indices, and C-reactive protein in type 2 diabetes with nephropathy: A longitudinal randomized clinical trial. Diabetes Care 2008;31:648-654.
64. Ribstein J, du Cailar G, Mimran A. Combined renal effects of overweight and hypertension. Hypertension 1995;26:610-615.
65. Chagnac A, Weinstein T, Herman M, Hirsh J, Gafter U, Ori Y. The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol 2003;14:1480-1486. (Pubitemid 36687049)
66. Pruijm M, Wuerzner G, Maillard M, Bovet P, Renaud C, Bochud M. Glomerular hyperfiltration and increased proximal sodium reabsorption in subjects with type 2 diabetes or impaired fasting glucose in a population of the African region. Nephrol Dial Transplant 2010;25:2225-2231.
67. Christiansen JS, Parving HH. The relationship between kidney size and function in short-term diabetic patients. Diabetologia 1982;22:494.
68. Inomata S. Renal hypertrophy as a prognostic index for the progression of diabetic renal disease in non-insulin-dependent diabetes mellitus. J Diabetes Complications 1993;7:28-33. (Pubitemid 24009481)
69. Kontessis PA, Bossinakou I, Sarika L, Iliopoulou E, Papantoniou A, Trevisan R. Renal, metabolic, and hormonal responses to proteins of different origin in normotensive, nonproteinuric type I diabetic patients. Diabetes Care 1995;18:1233.
70. Rigalleau V, Garcia M, Lasseur C, Laurent F, Montaudon M, Raffaitin C, Barthe N, Beauvieux M-C, Vendrely B, Chauveau P, Combe C, Gin H. Large kidneys predict poor renal outcome in subjects with diabetes and chronic kidney disease. BMC Nephrol 2010;11:3.
71. Magee GM, Bilous RW, Cardwell CR, Hunter SJ, Kee F, Fogarty DG. Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis. Diabetologia 2009;52:691-697.
72. Tuomilehto J, Jousilahti P, Rastenyte D, Moltchanov V, Tanskanen A, Pietinen P. Urinary sodium excretion and cardiovascular mortality in Finland: A prospective study. Lancet 2001;17;357:848-851. (Pubitemid 32239370)
73. Verhave JC, Hillege HL, Burgerhof JG, Janssen WM, Gansevoort RT, Navis GJ. PREVEND Study Group. Sodium intake affects urinary albumin excretion especially in overweight subjects. J Intern Med 2004;256:324-330. (Pubitemid 39304344)
74. Spooren PF, Gans RO, Adèr HJ, Vermes I, Donker AJ. Urinary albumin excretion rate during angiotensin II infusion in microalbuminuric patients with insulin and non-insulindependent diabetes mellitus. Nephrol Dial Transplant 1997;12: 281-285. (Pubitemid 27090979)